Global Swine Reproductive and Respiratory Syndrome Vaccine Market Research Report 2020

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Research Report 2020

Table of Contents
1 Swine Reproductive and Respiratory Syndrome Vaccine Market Overview
1.1 Product Overview and Scope of Swine Reproductive and Respiratory Syndrome Vaccine
1.2 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Type
1.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Active Vaccine
1.2.3 Inactivated Vaccines
1.3 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Application
1.3.1 Swine Reproductive and Respiratory Syndrome Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Estimates and Forecasts
1.4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2015-2026
1.4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales 2015-2026
1.4.3 Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region: 2020 Versus 2026
2 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Competition by Manufacturers
2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Swine Reproductive and Respiratory Syndrome Vaccine Market Competitive Situation and Trends
2.5.1 Swine Reproductive and Respiratory Syndrome Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Swine Reproductive and Respiratory Syndrome Vaccine Players (Opinion Leaders)
3 Swine Reproductive and Respiratory Syndrome Vaccine Retrospective Market Scenario by Region
3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
3.3.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
3.3.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
3.4.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
3.4.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region
3.5.2 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
3.6.1 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
3.6.2 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
3.7.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Swine Reproductive and Respiratory Syndrome Vaccine Historic Market Analysis by Type
4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price Market Share by Type (2015-2020)
4.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Swine Reproductive and Respiratory Syndrome Vaccine Historic Market Analysis by Application
5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Swine Reproductive and Respiratory Syndrome Vaccine Business
6.1 ASCENT CORPORATION
6.1.1 Corporation Information
6.1.2 ASCENT CORPORATION Description, Business Overview and Total Revenue
6.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 ASCENT CORPORATION Products Offered
6.1.5 ASCENT CORPORATION Recent Development
6.2 Boehringer-Ingelheim
6.2.1 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.2.2 Boehringer-Ingelheim Description, Business Overview and Total Revenue
6.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Boehringer-Ingelheim Products Offered
6.2.5 Boehringer-Ingelheim Recent Development
6.3 MSD Animal Health
6.3.1 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.3.2 MSD Animal Health Description, Business Overview and Total Revenue
6.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 MSD Animal Health Products Offered
6.3.5 MSD Animal Health Recent Development
6.4 SPAH
6.4.1 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.4.2 SPAH Description, Business Overview and Total Revenue
6.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 SPAH Products Offered
6.4.5 SPAH Recent Development
6.5 Ceva
6.5.1 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.5.2 Ceva Description, Business Overview and Total Revenue
6.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Ceva Products Offered
6.5.5 Ceva Recent Development
6.6 Chengdu TECH-BANK Biological Products Co,.Ltd
6.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Description, Business Overview and Total Revenue
6.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Products Offered
6.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Development
6.7 ringpu
6.6.1 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.6.2 ringpu Description, Business Overview and Total Revenue
6.6.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 ringpu Products Offered
6.7.5 ringpu Recent Development
6.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
6.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Description, Business Overview and Total Revenue
6.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Products Offered
6.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Development
6.9 DAHUANONG
6.9.1 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.9.2 DAHUANONG Description, Business Overview and Total Revenue
6.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 DAHUANONG Products Offered
6.9.5 DAHUANONG Recent Development
6.10 CAVAC
6.10.1 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.10.2 CAVAC Description, Business Overview and Total Revenue
6.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.10.4 CAVAC Products Offered
6.10.5 CAVAC Recent Development
6.11 Komipharm
6.11.1 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.11.2 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Description, Business Overview and Total Revenue
6.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Komipharm Products Offered
6.11.5 Komipharm Recent Development
6.12 Agrovet
6.12.1 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.12.2 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Description, Business Overview and Total Revenue
6.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Agrovet Products Offered
6.12.5 Agrovet Recent Development
6.13 Bioveta
6.13.1 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.13.2 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Description, Business Overview and Total Revenue
6.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Bioveta Products Offered
6.13.5 Bioveta Recent Development
6.14 JINYU BIO-TECNOLOGY CO.,LTD
6.14.1 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.14.2 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Description, Business Overview and Total Revenue
6.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.14.4 JINYU BIO-TECNOLOGY CO.,LTD Products Offered
6.14.5 JINYU BIO-TECNOLOGY CO.,LTD Recent Development
6.15 Phibro Animal Health
6.15.1 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.15.2 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Description, Business Overview and Total Revenue
6.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Phibro Animal Health Products Offered
6.15.5 Phibro Animal Health Recent Development
6.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
6.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Description, Business Overview and Total Revenue
6.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Products Offered
6.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Development
6.17 Zoetis
6.17.1 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.17.2 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Description, Business Overview and Total Revenue
6.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Zoetis Products Offered
6.17.5 Zoetis Recent Development
6.18 WINSUN BIO
6.18.1 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.18.2 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Description, Business Overview and Total Revenue
6.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.18.4 WINSUN BIO Products Offered
6.18.5 WINSUN BIO Recent Development
6.19 PULIKE BIOLOGICAL ENGINERING,INC.
6.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Production Sites and Area Served
6.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Description, Business Overview and Total Revenue
6.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Products Offered
6.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Recent Development
7 Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Cost Analysis
7.1 Swine Reproductive and Respiratory Syndrome Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Swine Reproductive and Respiratory Syndrome Vaccine
7.4 Swine Reproductive and Respiratory Syndrome Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors List
8.3 Swine Reproductive and Respiratory Syndrome Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Swine Reproductive and Respiratory Syndrome Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Swine Reproductive and Respiratory Syndrome Vaccine by Type (2021-2026)
10.2 Swine Reproductive and Respiratory Syndrome Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Swine Reproductive and Respiratory Syndrome Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Swine Reproductive and Respiratory Syndrome Vaccine by Application (2021-2026)
10.3 Swine Reproductive and Respiratory Syndrome Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Swine Reproductive and Respiratory Syndrome Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Swine Reproductive and Respiratory Syndrome Vaccine by Region (2021-2026)
10.4 North America Swine Reproductive and Respiratory Syndrome Vaccine Estimates and Projections (2021-2026)
10.5 Europe Swine Reproductive and Respiratory Syndrome Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Covered in This Study
Table 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Swine Reproductive and Respiratory Syndrome Vaccine Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Sales Sites and Area Served
Table 11. Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Product Types
Table 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Swine Reproductive and Respiratory Syndrome Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Swine Reproductive and Respiratory Syndrome Vaccine as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Swine Reproductive and Respiratory Syndrome Vaccine Players
Table 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Region (2015-2020)
Table 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2015-2020) (K Units)
Table 21. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2015-2020) (K Units)
Table 25. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2015-2020) (K Units)
Table 33. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Type (2015-2020)
Table 41. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Type (2015-2020)
Table 42. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Type (2015-2020)
Table 45. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Application (2015-2020)
Table 46. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 49. ASCENT CORPORATION Description and Business Overview
Table 50. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. ASCENT CORPORATION Main Product
Table 52. ASCENT CORPORATION Recent Development
Table 53. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 54. Boehringer-Ingelheim Corporation Information
Table 55. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Boehringer-Ingelheim Main Product
Table 57. Boehringer-Ingelheim Recent Development
Table 58. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 59. MSD Animal Health Corporation Information
Table 60. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. MSD Animal Health Main Product
Table 62. MSD Animal Health Recent Development
Table 63. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 64. SPAH Corporation Information
Table 65. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. SPAH Main Product
Table 67. SPAH Recent Development
Table 68. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 69. Ceva Corporation Information
Table 70. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Ceva Main Product
Table 72. Ceva Recent Development
Table 73. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 74. Chengdu TECH-BANK Biological Products Co,.Ltd Corporation Information
Table 75. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Chengdu TECH-BANK Biological Products Co,.Ltd Main Product
Table 77. Chengdu TECH-BANK Biological Products Co,.Ltd Recent Development
Table 78. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 79. ringpu Corporation Information
Table 80. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. ringpu Main Product
Table 82. ringpu Recent Development
Table 83. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 84. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Corporation Information
Table 85. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Main Product
Table 87. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Development
Table 88. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 89. DAHUANONG Corporation Information
Table 90. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. DAHUANONG Main Product
Table 92. DAHUANONG Recent Development
Table 93. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 94. CAVAC Corporation Information
Table 95. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. CAVAC Main Product
Table 97. CAVAC Recent Development
Table 98. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 99. Komipharm Corporation Information
Table 100. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Komipharm Main Product
Table 102. Komipharm Recent Development
Table 103. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 104. Agrovet Corporation Information
Table 105. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Agrovet Main Product
Table 107. Agrovet Recent Development
Table 108. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 109. Bioveta Corporation Information
Table 110. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Bioveta Main Product
Table 112. Bioveta Recent Development
Table 113. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 114. JINYU BIO-TECNOLOGY CO.,LTD Corporation Information
Table 115. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. JINYU BIO-TECNOLOGY CO.,LTD Main Product
Table 117. JINYU BIO-TECNOLOGY CO.,LTD Recent Development
Table 118. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 119. Phibro Animal Health Corporation Information
Table 120. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Phibro Animal Health Main Product
Table 122. Phibro Animal Health Recent Development
Table 123. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 124. ANHUI TIANKANG(GROUP)SHRES O., LTD Corporation Information
Table 125. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. ANHUI TIANKANG(GROUP)SHRES O., LTD Main Product
Table 127. ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Development
Table 128. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 129. Zoetis Corporation Information
Table 130. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Zoetis Main Product
Table 132. Zoetis Recent Development
Table 133. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 134. WINSUN BIO Corporation Information
Table 135. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. WINSUN BIO Main Product
Table 137. WINSUN BIO Recent Development
Table 138. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Corporation Information
Table 139. PULIKE BIOLOGICAL ENGINERING,INC. Corporation Information
Table 140. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. PULIKE BIOLOGICAL ENGINERING,INC. Main Product
Table 142. PULIKE BIOLOGICAL ENGINERING,INC. Recent Development
Table 143. Sales Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Swine Reproductive and Respiratory Syndrome Vaccine Distributors List
Table 146. Swine Reproductive and Respiratory Syndrome Vaccine Customers List
Table 147. Market Key Trends
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) Forecast by Type (2021-2026)
Table 151. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 152. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 153. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 154. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) Forecast by Application (2021-2026)
Table 155. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 156. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 157. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 158. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 159. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Swine Reproductive and Respiratory Syndrome Vaccine
Figure 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Active Vaccine Product Picture
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 6. Government Tender
Figure 7. Market Sales
Figure 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size 2015-2026 (US$ Million)
Figure 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Capacity (K Units) (2015-2026)
Figure 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 11. Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Manufacturers in 2020
Figure 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers in 2019
Figure 13. The Global 5 and 10 Largest Players: Market Share by Swine Reproductive and Respiratory Syndrome Vaccine Revenue in 2019
Figure 14. Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Swine Reproductive and Respiratory Syndrome

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs